Harvey Lodish

Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA.

Boston Children's Heart Foundation, Inc. is an organization that focuses on graduate medical education at Boston Children's Hospital. Additionally, they provide resources and information on kidney stones and how to transfer a patient to Boston Children's Hospital for treatment. The private company is based in Boston, MA. The company is committed to educating and preparing physicians for excellence in their field. The CEO of the company is Kevin B. Churchwell.

Children's Hospital Corp. engages in the provision of pediatric care services. It offers acupuncture, angioplasty, antibiotic allergy testing, audiogram, baclofen pump, biochemical genetic testing, blended diet, bone scan, brain scan, breast augmentation surgery, cardiac catheterization, cardiac MRI in children, chest reconstruction surgery, and CO2 laser treatment. The company was founded by Francis Henry Brown in 1869 and is headquartered in Boston, MA.

The Children's Medical Center Corp. operates as a non-profit hospital and research center. The company was founded in 1959 and is headquartered in Boston, MA.

Rubius Therapeutics, Inc. engages in the development of red-cell therapeutic medicines. It provides medicine for cancer, autoimmune diseases, hemophilia, infectious and metabolic diseases. The company was founded on April 26, 2013 and is headquartered in Foxboro, MA.

Esco Ventures Pte Ltd (Esco Ventures) is a venture capital firm founded in 2014 by Mr. Dr Nir Arbel and XiangQian (XQ) Lin. The firm is headquartered in Singapore.

Tevard Biosciences, Inc. is a biotechnology company based in Cambridge, MA. Tevard Biosciences is focused on developing trna-based and other modulating therapies to cure a broad range of genetic diseases. The company is advancing the use of its novel suppressor trna, enhancer trna, and mrna amplifier platforms in neurological disorders, heart disease, and muscular dystrophies. The company was founded in 2017 by Warren Burt Lammert, Harvey F. Lodish, Daniel Fischer, and Jeffrey Coller. Daniel Fischer has been the CEO since 2017.

Carmine Therapeutics Pte Ltd. develops and manufactures medicines based on red blood cell extracellular vesicles. The company was founded by Harvey Lodish, Minh Le, XiangQian Lin and Jiahai Shi in 2019 and is headquartered in Singapore.